4.2% Sodium Bicarbonate Injection, USP and 1% and 2% Lidocaine HCl Injection, USP by Hospira: Recall
Quarter 1 - 2023 Newsletter
FDA Investigating Certain Imported Medical Gloves
Teligent Pharma Voluntary Recall Lidocain Topical 4%
Select Monoject Flush Prefilled Saline Syringes By Cardinal Health: Recall
Specific NEUTROGENA and AVEENO Aerosol Sunscreen Products by Johnson & Johnson: Recall
Statins: Drug Safety Communication - FDA Requests Removal of Strongest Warning Against Statins
Surgical Procedure Packs by DeRoyal Industries: Class I Recall - Due to Mislabeled Lidocaine
Viona Pharmaceuticals Voluntary Recall of Metformin ER
FDA Restricts Use of Ocaliva in Primary Biliary Cholangitis Patients with Advanced Cirrhosis
Lamictal increases risk of arrhythmias in patients with Heart Disease
FAQs for Pharmacists on Naloxone Co-Prescribing
The Benadryl Challenge
Dangerous Wrong-Route Errors with Tranexamic Acid